Proteonomix, Inc., (OTCBB:PROT.OB) has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Michael Cohen, President of Proteonomix, stated: "This is another step in the development of our intellectual property and getting StromaCel into the commercial market. The technology covered by the patent application will reduce the cost to the patient of this type of treatment and when trials are completed and regulatory approvals are obtained we believe that the stromal cell technology will have major importance in the treatment of cardiac damage caused by heart attacks."

Without going into proprietary details, Mr. Cohen noted that the application relates to cell line expansion that he believes represents a fundamental improvement in the efficiency of producing stem cells which should have applications far beyond the cardiac therapy to which the present application relates.

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.'s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix's operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI") intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

*******************************************************

Administaff Inc. (NYSE: ASF) a leading provider of human resources services for small and medium-sized businesses, announced on September 29, 2010 the launch of its newly rebranded human resources (HR) software division, PerformSmart, formerly marketed as HRTools. PerformSmart is a division of Administaff, which offers software in both a Software-as-a-Service (SaaS) and desktop model to help businesses improve employee performance.

Administaff, Inc., a professional employer organization, provides various personnel management services in the United States. Its services include benefits and payroll administration, health and workers’ compensation insurance programs, personnel records management, employer liability management, employee recruiting and selection, employee performance management, and employee training and development services to small and medium-sized businesses.

*******************************************************

Advance Auto Parts Inc. (NYSE: AAP) leading automotive aftermarket retailer of parts, batteries, accessories, and maintenance items, announced on October 8, 2010 that its corporate credit rating has been upgraded to investment-grade status by Moody’s to Baa3. In April 2010, Advance Auto Parts was also upgraded to investment grade status (BBB-) by Standard & Poor’s. The Company has now achieved full investment grade status.

Advance Auto Parts, Inc., through its subsidiaries, operates as a retailer of automotive aftermarket parts, accessories, batteries, and maintenance items to do-it-yourself (DIY) and do-it-for-me customers.

*******************************************************

Advantest Corp. (NYSE: ATE) the world’s leading supplier of semiconductor test equipment, and OptimalTest, the leader in Advanced Adaptive Test and enterprise-wide test management and optimization software for the semiconductor industry, announce the availability of OptimalTest’s solutions for totally automated, integrated advanced adaptive test on Advantest’s T2000 High Performance Open Architecture test platform. By enabling T2000 testers and test cells with OptimalTest’s solutions, Advantest will augment the T2000’s industry-recognized high performance and cost benefits for SoC production test with the ability to achieve further significant improvements in yield; early detection of product, process and operational issues; reliability; reduced test time; production quality and Overall Equipment Efficiency (OEE) while keeping test costs low.

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)